These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12520176)

  • 1. Drug delivery to the eye with a transdermal therapeutic system.
    Isowaki A; Ohtori A; Matsuo Y; Tojo K
    Biol Pharm Bull; 2003 Jan; 26(1):69-72. PubMed ID: 12520176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a stick-type transdermal eyelid delivery system of ketotifen fumarate for ophthalmic diseases.
    Kimura C; Tojo K
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1002-5. PubMed ID: 17603189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of the ocular therapeutic effect of prednisolone acetate by liposomal entrapment.
    Elbialy NS; Abdol-Azim BM; Shafaa MW; El Shazly LH; El Shazly AH; Khalil WA
    J Biomed Nanotechnol; 2013 Dec; 9(12):2105-16. PubMed ID: 24266264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoresis: a non-invasive ocular drug delivery.
    Eljarrat-Binstock E; Domb AJ
    J Control Release; 2006 Feb; 110(3):479-89. PubMed ID: 16343678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular drug delivery-eye on innovation.
    Rupenthal ID; O'Rourke M
    Drug Deliv Transl Res; 2016 Dec; 6(6):631-633. PubMed ID: 27766597
    [No Abstract]   [Full Text] [Related]  

  • 6. Critical role for drug delivery in the development of new ophthalmic treatments.
    Sheardown H
    Future Med Chem; 2012 Nov; 4(17):2123-5. PubMed ID: 23190096
    [No Abstract]   [Full Text] [Related]  

  • 7. A pharmacokinetic model for ocular drug delivery.
    Tojo K
    Chem Pharm Bull (Tokyo); 2004 Nov; 52(11):1290-4. PubMed ID: 15516748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of therapeutics for deep-seated ocular conditions - status quo.
    Nguyen H; Eng S; Ngo T; Dass CR
    J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular drug delivery.
    Ghate D; Edelhauser HF
    Expert Opin Drug Deliv; 2006 Mar; 3(2):275-87. PubMed ID: 16506953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in topical nano drug-delivery systems for the anterior ocular segment.
    Lakhani P; Patil A; Majumdar S
    Ther Deliv; 2018 Feb; 9(2):137-153. PubMed ID: 29325511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery systems for the eye.
    Kearns VR; Williams RL
    Expert Rev Med Devices; 2009 May; 6(3):277-90. PubMed ID: 19419285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug delivery systems for intraocular applications].
    Bourges JL; Touchard E; Kowalczuk L; Berdugo M; Thomas-Doyle A; Bochot A; Gomez A; Azan F; Gurny R; Behar-Cohen F
    J Fr Ophtalmol; 2007 Dec; 30(10):1070-88. PubMed ID: 18268450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo real-time monitoring system of electroporation mediated control of transdermal and topical drug delivery.
    Blagus T; Markelc B; Cemazar M; Kosjek T; Preat V; Miklavcic D; Sersa G
    J Control Release; 2013 Dec; 172(3):862-71. PubMed ID: 24113487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of drug-in-adhesive patch formulations for transdermal delivery of fluoxetine: In vitro and in vivo evaluations.
    Jung E; Lee EY; Choi HK; Ban SJ; Choi SH; Kim JS; Yoon IS; Kim DD
    Int J Pharm; 2015 Jun; 487(1-2):49-55. PubMed ID: 25863117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug delivery to the posterior segment of the eye.
    Fischer N; Narayanan R; Loewenstein A; Kuppermann BD
    Eur J Ophthalmol; 2011; 21 Suppl 6():S20-6. PubMed ID: 23264325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Permeation enhancer strategies in transdermal drug delivery.
    Marwah H; Garg T; Goyal AK; Rath G
    Drug Deliv; 2016; 23(2):564-78. PubMed ID: 25006687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.
    Shen J; Lu GW; Hughes P
    Pharm Res; 2018 Sep; 35(11):217. PubMed ID: 30255364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.